Dahdaleh Institute for Global Health Research, York University, 4700 Keele Street, Toronto, Canada.
Askew School of Administration and Policy, South Florida University, 113 Collegiate Loop, Tallahassee, FL, 32306, USA.
Glob Health Res Policy. 2024 Sep 19;9(1):37. doi: 10.1186/s41256-024-00380-z.
Cervical cancer is a preventable disease that continues to burden socioeconomically underserved regions, especially in Africa. Vaccination of adolescents who have never had sex with prophylactic human papillomavirus (HPV) vaccines proves effective in preventing the disease. However, vaccine accessibility and availability are two persistent challenges in low-resource settings. For this commentary, a trend analysis is conducted for national HPV vaccination and coverage rates in Africa, a region with high burden of the disease. This is in consideration of the World Health Organization (WHO) strategy to vaccinate 90% of adolescent girls by the age of 15, as part of strategy to eliminate cervical cancer by 2030. The analysis estimated that the rate of incorporating HPV vaccination in national immunization programs in Africa occurs slowly, at a mean wait time of 12 years with estimated coverage rate of 52%. A policy change that harnesses strategic approaches, such as a regionalized vaccination program, is recommended to hasten HPV vaccination for the rest of African countries without a national program.
宫颈癌是一种可预防的疾病，在社会经济服务不足的地区（尤其是非洲）仍然存在负担。为从未发生过性行为的青少年接种预防性人乳头瘤病毒 (HPV) 疫苗已被证明可有效预防该疾病。然而，在资源匮乏的环境中，疫苗的可及性和可获得性仍然是两个持续存在的挑战。本评论对疾病负担较高的非洲地区的国家 HPV 疫苗接种和覆盖率进行了趋势分析。这是考虑到世界卫生组织 (WHO) 的战略，即在 2030 年消除宫颈癌之前，为 90%的 15 岁少女接种疫苗。分析估计，非洲国家免疫规划中纳入 HPV 疫苗的速度较慢，平均等待时间为 12 年，估计覆盖率为 52%。建议采取一种区域性疫苗接种计划等战略方法的政策变革，以加快非洲尚无国家方案的其余国家的 HPV 疫苗接种。
